Bladder Cancer Clinical Trial

Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors

Summary

The purpose of this pilot study is to determine if washing out the bladder with large volumes of saline after surgical removal of bladder tumors helps to decrease the number of loose cells floating within the bladder after surgery. Anticipated decrease in tumor recurrence and/or progression rates will be measured.

View Full Description

Full Description

Bladder tumor recurrence after resection of non-muscle invasive bladder cancer (NMIBC) occurs in 50-70% of patients despite the use of adjuvant anticancer therapy after surgery. This is a single-arm, non-randomized pilot study looking to determine whether post-Transurethral Resection of Bladder Tumor (TURBT) cells counts differ significantly between continuous washout of the bladder (CBI) with normal saline compared to pre-CBI wash out. Anticipated decrease in tumor recurrence and/or progression rates will also be measured, and each participant will act as their own internal control.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients age 18 years and older diagnosed with a bladder mass on cystoscopy or imaging study
Primary bladder tumor occurrence

Exclusion Criteria:

Patients with unresectable bladder tumors, as determined at the time of diagnosis or TURBT , or imaging concerning of T2 or higher disease
Patients with bladder perforation at the time of TURBT, which is a contraindication to CBI
Patients from vulnerable populations, including but not limited to impaired subjects, pregnant women, prisoners, family members of the study team
Any previous history of bladder tumor resection or intravesical chemotherapy/immunotherapy
History of previous pelvic radiation
Bladder tumor volume > 5 cm, involvement of prostatic urethra, or any evidence of hydronephrosis on imaging

Study is for people with:

Bladder Cancer

Study ID:

NCT03839472

Recruitment Status:

Withdrawn

Sponsor:

Case Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland Ohio, 44106, United States

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Study ID:

NCT03839472

Recruitment Status:

Withdrawn

Sponsor:


Case Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider